The European legislation on medical devices (MDR) and in vitro diagnostic medical devices (IVDR) require each authority to evaluate the functioning of its market surveillance activities at least every four years and to publish a public summary for that purpose (Article 93(8) of the MDR and Article 88(8) of the IVDR).
In this context, the AFMPS hereby makes available a summary of the results of the market surveillance activities carried out in Belgium for the period 2022–2025.
This document provides a concise overview of the main actions, findings and achievements, as well as of the European and national cooperation activities supporting market surveillance.
Summary of the results of the market surveillance activities
Last updated on